Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Intarcia’s Fight To Win ITCA 650 Approval: Former Employees Object To FDA AdComm Presentations
Oct 25 2023
•
By
Brenda Sandburg
Former Intarcia employees back company in dispute with FDA over diabetes drug-device combo product. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers